BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14571085)

  • 1. Mast cells in atopic dermatitis: resistance against medium-dose UVA1 phototherapy?
    Breuckmann F; von Kobyletzki G; Avermaete A; Kreuter A; Altmeyer P; Gambichler T
    Dermatology; 2003; 207(3):334-6. PubMed ID: 14571085
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.
    Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study.
    Gambichler T; Othlinghaus N; Tomi NS; Holland-Letz T; Boms S; Skrygan M; Altmeyer P; Kreuter A
    Br J Dermatol; 2009 Mar; 160(3):652-8. PubMed ID: 19120333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'High dose' vs. 'medium dose' UVA1 phototherapy in italian patients with severe atopic dermatitis.
    Pacifico A; Iacovelli P; Damiani G; Ferraro C; Cazzaniga S; Conic RRZ; Leone G; Morrone A
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):718-724. PubMed ID: 30468530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phototherapy in severe atopic dermatitis. Comparison between current UVA1 therapy, UVA1 cold light and combined UVA-UVB therapy].
    von Kobyletzki G; Freitag M; Herde M; Höxtermann S; Stücker M; Hoffmann K; Altmeyer P
    Hautarzt; 1999 Jan; 50(1):27-33. PubMed ID: 10068928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy.
    Breuckmann F; von Kobyletzki G; Avermaete A; Pieck C; Kreuter A; Brockmeyer NH; Altmeyer P; Gambichler T
    Eur J Med Res; 2002 Jul; 7(7):315-22. PubMed ID: 12176681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-dose ultraviolet A1 phototherapy and mRNA expression of TSLP, TARC, IL-5, and IL-13 in acute skin lesions in atopic dermatitis.
    Bogaczewicz J; Malinowska K; Sysa-Jedrzejowska A; Wozniacka A
    Int J Dermatol; 2016 Aug; 55(8):856-63. PubMed ID: 26475182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis.
    Legat FJ; Hofer A; Brabek E; Quehenberger F; Kerl H; Wolf P
    Arch Dermatol; 2003 Feb; 139(2):223-4. PubMed ID: 12588233
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis.
    Krutmann J; Czech W; Diepgen T; Niedner R; Kapp A; Schöpf E
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):225-30. PubMed ID: 1552057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phototherapy in the management of atopic dermatitis: a systematic review.
    Meduri NB; Vandergriff T; Rasmussen H; Jacobe H
    Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):106-12. PubMed ID: 17598862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of nonresponders in high dosage UVA1 therapy of acute exacerbated atopic dermatitis].
    Schempp CM; Effinger T; Czech W; Krutmann J; Simon JC; Schöpf E
    Hautarzt; 1997 Feb; 48(2):94-9. PubMed ID: 9173067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies.
    Gambichler T; Terras S; Kreuter A
    Clin Dermatol; 2013; 31(4):438-454. PubMed ID: 23806161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Safety and Efficacy of Narrow Band Ultraviolet B Treatment in Dermatology: A Review.
    Sokolova A; Lee A; D Smith S
    Am J Clin Dermatol; 2015 Dec; 16(6):501-31. PubMed ID: 26369540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose ultraviolet A1 (UVA1) phototherapy: does it work?
    Krutmann J
    Photodermatol Photoimmunol Photomed; 1997 Jun; 13(3):78-81. PubMed ID: 9372519
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema.
    Grabbe J; Welker P; Humke S; Grewe M; Schöpf E; Henz BM; Krutmann J
    J Invest Dermatol; 1996 Sep; 107(3):419-22. PubMed ID: 8751980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultraviolet A1 phototherapy.
    Dawe RS
    Br J Dermatol; 2003 Apr; 148(4):626-37. PubMed ID: 12752118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Narrow-band medium-wave ultraviolet therapy in patients with atopic dermatitis: efficacy and safety].
    Kubanov AA; Chikin VV; Karamova AE; Monchakovskaya ES
    Vopr Kurortol Fizioter Lech Fiz Kult; 2022; 99(6):79-88. PubMed ID: 36538407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial.
    Krutmann J; Diepgen TL; Luger TA; Grabbe S; Meffert H; Sönnichsen N; Czech W; Kapp A; Stege H; Grewe M; Schöpf E
    J Am Acad Dermatol; 1998 Apr; 38(4):589-93. PubMed ID: 9555799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phototherapy for atopic dermatitis.
    Rodenbeck DL; Silverberg JI; Silverberg NB
    Clin Dermatol; 2016; 34(5):607-13. PubMed ID: 27638440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium-dose ultraviolet A1 phototherapy improves SCORAD index and increases mRNA expression of interleukin-4 without direct effect on human β defensin-1, interleukin-10, and interleukin-31.
    Bogaczewicz J; Malinowska K; Sysa-Jedrzejowska A; Wozniacka A
    Int J Dermatol; 2016 Jul; 55(7):e380-5. PubMed ID: 26748443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.